转自：云南日报 责任编辑：孙重远 肾脏移植采用经典异位移植术式，血流开放后，移植肾即刻色泽红润，尿液自输尿管顺利流出。观察期 内，移植肾脏尿量逐渐增多，总尿量达4000余毫升，单日最高超1800毫升，达到正常生理状态。 本次移植肝脏产生的胆汁量已接近正常生理水平，据公开报道，这是目前全球异种肝移植同类研究中胆 汁分泌功能的最佳水平。此次研究全程经过严格伦理审查，第11天，应受试者家属的要求终止研究。 本次移植使用的供体猪来自国内自主培育的医用猪品系，符合DPF（无指定病原体）级生物安全标准， 通过基因编辑技术精准敲除3个猪抗原基因、转入2个人补体调节蛋白基因和1个人凝血调节蛋白基因 ——以"六基因"的核心策略，有效应对异种器官移植中的免疫排斥与凝血紊乱两大核心障碍。供体猪器 官的获取在中国科学院昆明动物研究所完成。 本次研究更贴近临床应用场景，团队采用的原位辅助部分肝移植术式，保留受者部分自体肝脏，让异种 肝脏与自体肝脏协同工作，更契合未来"桥接治疗"的临床需求，即用猪肝暂时替代衰竭肝脏功能，为患 者自体肝再生或等待人源供肝争取时间。 此次突破为我国乃至全球通过异种移植解决器官短缺难题提供了宝贵的数据依据，为 ...

Core Insights - The field of xenotransplantation has made significant advancements in 2025, achieving breakthroughs that surpass the last century's progress [1] - A genetically edited pig kidney was successfully transplanted into a patient, Tim Andrews, who survived for 271 days, setting a new record for pig kidney transplants [1][2] - The comparison with a historical case from 1964 shows only a marginal improvement in survival time for xenotransplantation over 60 years [2] Group 1: Historical Context and Comparisons - The previous record for xenotransplantation was held by a female teacher who survived 269 days after receiving a chimpanzee kidney [2][3] - The advancements in genetic editing and immunosuppressive therapies have contributed to the increased survival time of xenotransplant patients [2][3] Group 2: Challenges and Limitations - Current challenges in xenotransplantation include immune rejection, infection risks, and biological compatibility issues [6][7] - The use of genetically modified pigs is preferred over primates due to ethical concerns, biological safety risks, and practical breeding considerations [5][6] Group 3: Technological and Regulatory Hurdles - Gene editing techniques have limitations, including the potential for new antigen production and the complexity of determining effective gene combinations [8][9] - Immunosuppressive drugs currently used are not specifically designed for xenotransplantation, leading to complications such as infections and organ toxicity [11][12] Group 4: Future Prospects and Comparisons with Artificial Organs - The development of artificial organs, particularly artificial hearts, is progressing rapidly, with several products nearing market readiness [13][15] - In contrast, the development of artificial kidneys and livers faces significant challenges, making them less competitive with xenotransplantation at this stage [16][17] Group 5: Expert Opinions and Future Directions - Experts believe that achieving a one-year functional survival for xenotransplanted organs could lead to broader acceptance and further advancements in the field [18]

Core Insights - The field of xenotransplantation has made significant advancements in 2025, surpassing breakthroughs achieved in the past century, particularly highlighted by the case of a genetically edited pig kidney functioning in a human for 271 days [1][2] - The comparison between the recent pig kidney transplant and a historical chimpanzee kidney transplant reveals only a marginal improvement in survival time, raising questions about the progress in xenotransplantation compared to other medical advancements like artificial hearts [1][5] Summary by Sections Historical Context - The longest survival record for a kidney transplant from a chimpanzee was set in 1964, lasting 269 days, while the recent pig kidney transplant extended this record to 271 days [2][5] - The historical context shows that despite over 60 years of research, the improvement in survival time for xenotransplantation has been minimal when compared to advancements in other areas of organ transplantation [1][5] Technological Advancements - The recent case of Tim Andrews demonstrates the potential of genetically edited pig kidneys, which have been modified to enhance compatibility with human immune systems [1][9] - The use of modern immunosuppressive therapies has allowed for longer survival times in xenotransplantation, indicating progress in managing immune rejection [6][10] Challenges and Limitations - The field faces significant challenges, including the need for more effective immunosuppressive drugs specifically designed for xenotransplantation, as current medications are primarily developed for same-species transplants [15][17] - The approval process for clinical trials in xenotransplantation varies significantly between countries, with the U.S. having a more structured approach compared to China's relatively unregulated environment [17] Future Prospects - The potential for xenotransplantation to provide a sustainable source of organs is promising, especially given the increasing demand for organ transplants and the shortage of human donors [10][18] - The development of artificial organs, particularly artificial hearts, is advancing rapidly, which may create competition for xenotransplantation in the future [18][22] Ethical and Practical Considerations - Ethical concerns regarding the use of primate organs have shifted the focus to pigs, which are more practical for large-scale organ production and genetic modification [9][19] - The complexity of developing artificial kidneys and livers remains a significant barrier, with current technologies not yet capable of producing viable implantable organs [22][23]

Core Viewpoint - The first successful xenotransplantation of a pig kidney into a macaque has resulted in the recipient surviving for over a year, marking a significant advancement in addressing the global organ shortage issue [1][2]. Group 1: Research and Development - The experiment was conducted by the team led by Chen Gang at Tongji Hospital, Huazhong University of Science and Technology [1]. - This case is the first of its kind outside the United States, providing a crucial scientific foundation for solving clinical organ shortages [1]. - The research team has been working in the field of xenotransplantation since 1999 and has made significant progress, including the use of genetically edited pigs in 2019 [1]. Group 2: Challenges and Breakthroughs - Xenotransplantation faces significant challenges, including severe immune rejection reactions [1]. - The research team identified two key issues: porcine cytomegalovirus and precise immunosuppression, which they successfully addressed [1]. - The recipient macaque has stable physiological indicators and remains in good health after over a year [1]. Group 3: Future Prospects - Chen Gang expressed that xenotransplantation offers hope for terminally ill patients with no available organs and aims to address the global organ shortage [2]. - The team anticipates advancing this technology to clinical application within the next three to five years [2].

Core Viewpoint - United Therapeutics has initiated the first clinical trial of gene-edited pig kidney transplantation in humans, marking a significant step towards large-scale clinical trials in this field [1][2]. Group 1: Clinical Trial Details - The trial is the first FDA-approved human transplantation of gene-edited pig kidneys, aimed at systematically evaluating the safety and efficacy for patients with end-stage renal disease [2]. - The initial phase will recruit 6 patients, with an independent data monitoring committee reviewing safety and efficacy data after at least 12 weeks post-surgery [2]. - If successful, the trial may expand to include up to 50 participants as more transplant centers join [2]. Group 2: Background and Significance - Previous cases of pig kidney transplantation were conducted under "compassionate use" rules for critically ill patients, but this trial allows for a more stable patient population [3]. - The trial represents a transition from individual cases to systematic clinical research, indicating technological maturity and a new phase in gene-edited organ transplantation [3]. - Another company, eGenesis, plans to start its own pig kidney clinical trial within months, aiming to complete 33 trials over the next two and a half years [3]. Group 3: Current Status and Challenges - As of early November, at least two patients (one in China and one in the U.S.) who received gene-edited pig kidney transplants are still alive [4]. - A notable case in China has seen a transplanted pig kidney functioning well for over 240 days, potentially setting a record for survival [5]. - The field of xenotransplantation aims to address the shortage of human organ donations, but challenges remain, including immune rejection and ensuring long-term organ viability [6][7].

Core Viewpoint - The successful transplantation of a genetically edited pig kidney into a human patient, Tim Andrews, has set a new record for survival duration, lasting 271 days, highlighting advancements in xenotransplantation and its potential to address organ shortages [1][2]. Group 1: Medical Advancements - Tim Andrews underwent a pig kidney transplant on January 25, which was genetically edited to enhance compatibility and reduce rejection risks [1]. - The pig kidney was edited at 69 sites, including the removal of genes that cause rejection and the addition of human genes to improve compatibility [1]. - Despite the advancements, Andrews experienced rejection reactions and had to have the kidney removed after 271 days due to the side effects of immunosuppressive drugs [2]. Group 2: Global Research Efforts - The U.S. has seen multiple attempts at xenotransplantation, with previous cases of pig kidney transplants lasting less than two months before rejection [1]. - Chinese medical teams are also making strides in this field, with a successful pig kidney transplant that has functioned for over 200 days, marking a significant achievement in Asia [2]. - Other organs, such as pig hearts, lungs, and livers, are being explored for transplantation to address the organ shortage crisis [3]. Group 3: Ethical and Research Considerations - There are ongoing concerns regarding the long-term health impacts of animal organ transplants on humans, as well as the quality of life for recipients [3]. - The field of xenotransplantation raises ethical, anthropological, and sociological questions that need to be addressed to ensure responsible implementation [3].

Core Insights - A record-setting event occurred as a man in the U.S. underwent a pig kidney transplant that lasted nearly 9 months before the kidney was removed due to failure, leading to the resumption of dialysis treatment [1][5]. Group 1: Transplant Details - The transplanted pig kidney functioned for 271 days, setting a new record for the survival duration of pig kidneys in similar trials [5]. - The recipient, Tim Andrews, a 67-year-old from New Hampshire, received the genetically edited pig kidney in January [5]. - The kidney underwent 69 genetic modifications to help prevent organ rejection and other complications [5]. Group 2: Research Implications - Tim Andrews' experience is expected to provide significant insights for the field of xenotransplantation research [5].

Core Insights - A 67-year-old patient in the U.S. underwent a pig kidney transplant that lasted nearly 9 months, setting a new record for the survival duration of genetically edited pig kidneys in human trials [1][2] - The pig kidney was genetically modified with 69 edits to reduce rejection risks and enhance compatibility with human biology [1] - Despite the advancements, the patient experienced organ rejection and side effects from immunosuppressive drugs, leading to the kidney's removal [1] Group 1: Transplant Details - The transplant was performed at Brigham and Women's Hospital on January 25, where the patient temporarily ceased dialysis after the procedure [1] - The kidney's survival duration of 9 months is significant compared to previous attempts with pig organs, which did not exceed a few months [2] Group 2: Research Implications - This trial provides valuable insights for future xenotransplantation research, which aims to address the shortage of human transplant organs [2] - Pigs are considered ideal candidates for organ donation due to their anatomical and physiological similarities to humans, although challenges remain [2]

Core Insights - A 67-year-old patient in the U.S. underwent a pig kidney transplant that lasted nearly 9 months, setting a new record for the survival duration of genetically edited pig kidneys in human trials [1] - The pig kidney was genetically modified with 69 edits to reduce rejection risks and improve compatibility with human organs [1] - Despite the advancements, the patient experienced organ rejection and side effects from immunosuppressive drugs, leading to the removal of the pig kidney [1] Group 1 - The transplant provided valuable insights for xenotransplantation research, highlighting the potential of genetically edited pig organs to address organ shortages [2] - Previous attempts to transplant genetically edited pig hearts, lungs, and livers into humans have not exceeded a few months of survival [2] - Pigs are considered ideal candidates for xenotransplantation due to the similarities in organ structure and physiological functions, although various risks and technical challenges remain [2]

Core Viewpoint - Recent breakthroughs in xenotransplantation using genetically edited pig organs have sparked global interest in addressing the shortage of human organ transplants [2][3][4]. Group 1: Milestones in Xenotransplantation - In October 2021, NYU Langone Medical Center performed the first successful transplant of a genetically edited pig kidney into a brain-dead woman [2]. - In January 2022, the University of Maryland conducted the first live transplant of a genetically edited pig heart, with the patient surviving for approximately two months [2]. - On March 27, 2025, Chinese scientists published the first case of a genetically edited pig liver transplant into a brain-dead human, with the liver functioning for 10 days without rejection [3]. - On October 8, 2025, the first live transplant of a genetically edited pig liver was successfully performed, with the patient surviving for 171 days, setting a new record [4][5]. Group 2: Technical Aspects of the Research - The genetically edited pig liver used in the transplant underwent rigorous pathogen screening and was modified at 10 genetic sites to prevent rejection [5]. - Key genes were knocked out to prevent acute rejection, while human genes were introduced to enhance immune compatibility [5]. - The patient had a significant liver tumor and was initially deemed unsuitable for surgical removal, making the pig liver a critical transitional therapy [5]. Group 3: Post-Transplant Outcomes - In the first 31 days post-transplant, the patient did not experience acute rejection or severe complications, and liver and kidney functions remained stable [6]. - However, on day 38, the patient developed thrombotic microangiopathy (xTMA), leading to the removal of the pig liver [6]. - Despite successful management of xTMA, the patient ultimately passed away on day 171 due to recurrent upper gastrointestinal bleeding [6][9]. Group 4: Implications for Future Research - The study demonstrates the feasibility of using pig livers as transitional support for patients with unresectable liver cancer or liver failure [9]. - It highlights the need for further research to improve outcomes in xenotransplantation, particularly regarding xTMA [6][9].